Suppression of acquired immunity against Listeria monocytogenes by amphotericin B-mediated inhibition of CD8 T cell function

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1186-1194

  Geginat, Gernot ^a   Kretschmar, Marianne ^a   Walter, Simon ^a   Junker, Dieter ^a   Hof, Herbert ^a   Nichterlein, Thomas ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELL FUNCTION; CELL TRANSFER; CONTROLLED STUDY; CYTOLYSIS; FEMALE; IMMUNE DEFICIENCY; IMMUNITY; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMPHOTERICIN B; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNITY, NATURAL; IMMUNOSUPPRESSION; IMMUNOTHERAPY, ADOPTIVE; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C;

EID: 0033399677     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315007     Document Type: Article

References (46)

1. Daar ES, Meyer RD. Medical management of AIDS patients. Bacterial and fungal infections. Med Clin North Am 1992; 76:173-203.
2. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91:72S-5S.
3. Warnock DW. Fungal complications of transplanation: diagnosis, treatment and prevention. J Antimicrob Chemother 1995; 36(Suppl B):73-90.
4. Hibherd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994; 19(Suppl 1):S33-40.
5. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12:308-29.
6. Edwards JE, Jr., Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997; 25:43-59.
7. Meyer RD. Current role of therapy with amphotericin B. Clin Infect Dis 1992; 14(Suppl 1):S154-60.
8. Warnock DW. Amphotericin B: an introduction. J Antimicrob Chemother 1991; 28(Suppl B):27-38.
9. Henry-Toulme N, Seman M, Bolard J. Interaction of amphotericin B and its N-fructosyl derivative with murine thymocytes: a comparative study using fluorescent membrane probes. Biochim Biophys Acta 1989; 982:245-52.
10. Rogers PD, Jenkins JK, Chapman SW, Ndebele K, Chapman BA, Cleary JD. Amphotericin B activation of human genes encoding for cytokines. J Infect Dis 1998; 178:1726-33.
11. Little JR, Shore V. Modulation by lipoproteins of amphotericin B-induced immunostimulation. Cell Immunol 1985; 93:212-21.
12. Schindler JJ, Warren RP, Alien SD, Jackson MK. Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice. Antimicrob Agents Chemother 1993; 37:2716-21.
13. Mehta RT, Mehta K, Lopez-Berestein G, Juliano RL. Effect of liposomal amphotericin B on murine macrophages and lymphocytes. Infect Immun 1985; 47:429-33.
14. Bernaudin F, Hathorn J, Schaufele R, Pizzo PA. In vitro effect of amphotericin B on polymorphonuclear chemotaxis and large granular lymphocytes with natural killer activity. Pathol Biol (Paris) 1987; 35:1403-7.
15. Hauser WE, Jr., Remington JS. Effect of amphotericin B on natural killer cell activity in vitro. J Antimicrob Chemother 1983; 11:257-62.
16. Boggs JM, Chang NH, Goundalkar A. Liposomal amphotericin B inhibits in vitro T-lymphocyte response to antigen. Antimicrob Agents Chemother 1991; 35:879-85.
17. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993; 11:129-63.
18. North RJ, Dunn PL, Conlan JW. Murine listeriosis as H model of antimicrobial defense. Immunol Rev 1997; 158:27-36.
19. Wagner JA, Kretschmar M, Nichterlein T, Hof H, Quade B. Failure of FK 506 to suppress the T cell mediated immunity of mice to Listeria monocytogenes. Clin Exp Immunol 1993; 92:473-6.
20. Steinmüller C, Roesler J, Grottrup E, Franke G, Wagner H, Lohmann-Matthes ML. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol 1993; 15:605-14.
21. Hugin AW, Cerny A, Wrann M, Hengartner H, Zinkernagel RM. Effect of cyclosporin A on immunity to Listeria monocytogenes. Infect Immun 1986; 52:12-7.
22. Strauss R, Heymer B, Hof H. Effects of cyclosporin A on experimental infection with Listeria monocytogenes. Clin Exp Immunol 1985; 62:491-8.
23. Schaffner A, Douglas H, Davis CE. Models of T cell deficiency in listeriosis: the effects of cortisone and cyclosporin A on normal and nude BALB/c mice. J Immunol 1983; 131:450-3.
24. Harty JT, Bevan MJ. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity 1995; 3:109-17.
25. Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 1993; 177:845-50.
26. Geginat G, Nichterlein T, Kretschmar M et al. Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua. J Immunol 1999; 162:4781-9.
27. Geginat G, Lalie M, Kretschmar M, et al. TH1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo. J Immunol 1998; 160:6046-55.
28. Leo O, Foo M, Henkart PA, et al. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies. J Immunol 1987; 139:3556-63.
29. Nichterlein T, Kretschmar M, Budeanu C, Bauer J, Linss W, Hof H. Bay Y 3H8, a new quinolone derivative, rapidly eradicates Listeria monocytagenes from infected mice and L929 cells. Antimicrob Agents Chemother 1994; 38:1501-6.
30. Brajtburg J, Elberg S, Kobayashi GS, Medoff G. Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice. Infect Immun 1986; 54:303-7.
31. Thomas MZ, Medoff G, Kobayashi GS. Changes in murine resistance to Listeria monocytogenes infection induced by amphotericin B. J Infect Dis 1973; 127:373-7.
32. Harty JT, Pamer EG. CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection. J Immunol 1995; 154:4642-50.
33. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 1987; 84:1374-8.
34. Kägi D, Vignaux F, Ledermann B, et al. Fas and perform pathways as major mechanisms of T cell mediated cytotoxicity. Science 1994; 265:528-30.
35. Pamer E, Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 1998; 16:323-58.
36. Kägi D, Ledermann B, Burki K, Hengartner H, Zinkernagel RM. CD8' T cell mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 1994; 24:3068-72.
37. Kataoka T, Takaku K, Magae J, et al. Acidification is essential for maintaining the structure and function of lytic granules of CTL: effect of concanamycin A, an inhibitor of vacuolar type II(+)-ATPase, on CTL-mediated cytotoxicity. J Immunol 1994; 153:3938-47.
38. Busch DH, Pilip IM, Vijh S, Pamer EG. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998; 8:353-62.
39. Sanders SW, Buchi KM, Goddard MS, Lang JK, Tolman KG. Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers. Antimicrob Agents Chemother 1991; 35:1029-34.
40. Chabot GG, Pazdur R, Valeriote FA, Baker LH. Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients. J Pharm Sci 1989; 78:307-10.
41. Christiansen KJ, Bernard EM, Gold JW, Armstrong D. Distribution and activity of amphotericin B in humans. J Infect Dis 1985; 152:1037-43.
42. Gondal JA, Swartz RP, Rahman A. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob Agents Chemother 1989; 33:1544-8.
43. Sabirov RZ, Manjosova MA, Tadjibaeva ET, Krasilnikov OV. The interaction of amphotericin B with cell membrane of rat thymocytes. Gen Physiol Biophys 1993; 12:249-57.
44. Walev I, Bhakdi S. Possible reason for preferential damage to renal tubular epithelial cells evoked by amphotericin B. Antimicrob Agents Chemother 1996; 40:1116-20.
45. Charretier E, Wietzerbin J. Intracellular alkalinization induced by amphotericin B derivatives in HL-60 leukemia cells. Biochimie 1989; 71:67-70.
46. Vertut-Doi A, Ohnishi SI, Bolard J. The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B. Antimicrob Agents Chemother 1994; 38:2373-9.